Prevalence and risk factors for thromboembolic complications in IBD patients

Details

Ressource 1Download: BIB_B7F2C3F1DB05.P001.pdf (679.67 [Ko])
State: Public
Version: Final published version
Serval ID
serval:BIB_B7F2C3F1DB05
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Poster: Summary – with images – on one page of the results of a researche project. The summaries of the poster must be entered in "Abstract" and not "Poster".
Collection
Publications
Institution
Title
Prevalence and risk factors for thromboembolic complications in IBD patients
Title of the conference
Journal of Crohn's & Colitis, Vol. 9 supl.1
Author(s)
Schoepfer A., Alatri A., Fournier N., Safroneeva E., Calanca L., Mazzolai L.
Organization
10th Congress of ECCO-European Crohns & Colitis Organisation : Inflammatory bowel diseases. 18-21 February 2015, Barcelona, Spain
ISBN
1873-9946
Publication state
Published
Issued date
2015
Peer-reviewed
Oui
Volume
9
Pages
S178-S179
Language
english
Notes
Poster Presentation P206
Abstract
Background: Inflammatory bowel disease (IBD) patients have an increased risk of venous thromboembolic complications (VTEC) such as deep vein thrombosis (DVT) and pulmonary embolism when compared to the non-IBD population. However, studies assessing VTEC prevalence in IBD as well as analyses of VTEC associated risk factors are scarce. We aimed to assess VTEC prevalence in IBD patients and to identify associated risk factors.
Methods: Data from patients enrolled in the Swiss IBD Cohort Study (SIBDCS) were analyzed. Since 2006 the SIBDCS collects data on a large sample of IBD patients from hospitals and private practices across Switzerland.
Results: A  total of 90/2284 (3.94%) IBD patients suffered from VTEC. Of these, 45/1324 (3.4% overall; 2.42% with DVT, 1.51% with PE) had CD, and 45/960 (4.7% overall; 3.23% with DVT, 2.40% with PE) presented with UC.
Web of science
Create date
12/06/2015 12:29
Last modification date
20/08/2019 16:26
Usage data